TISERCIN

This brand name is authorized in Estonia, Lithuania, Poland.

Active ingredients

The drug TISERCIN contains one active pharmaceutical ingredient (API):

1
UNII 9G0LAW7ATQ - LEVOMEPROMAZINE
 

Levomepromazine resembles chlorpromazine and promethazine in the pattern of its pharmacology. It possesses anti-emetic, antihistamine and anti-adrenaline activity and exhibits a strong sedative effect.
 
Read more about Levomepromazine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N05AA02 Levomepromazine N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AA Phenothiazines with aliphatic side-chain
Discover more medicines within N05AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1119192, 1119844
LT Valstybinė vaistų kontrolės tarnyba 1007134, 1007135, 1065153, 1085684, 1085840
PL Rejestru Produktów Leczniczych 100067018, 100067024

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈